Topiramate

Topiramate

SCHEMBL4980190

CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CA2CA4GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Topiramate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 20/20 1.00
CA4 known ✓ P22748 7/20 1.00
CA1 P00915 10/20 1.00
CA5A P35218 7/20 1.00
CA7 P43166 7/20 1.00
CA9 Q16790 7/20 1.00
CA14 Q9ULX7 7/20 1.00
CA12 O43570 2/20 1.00
CA5B Q9Y2D0 2/20 1.00
CA6 P23280 1/20 1.00
CA13 Q8N1Q1 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Topiramate SCHEMBL7859335 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL6341452 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL18898593 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL1274751 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL1534094 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL17343471 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL23468160 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL5637335 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL13575742 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7
Topiramate SCHEMBL34631 1.00 CA2 (1.00) CA2CA1CA4CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351695-B2 Topiramate salts and compositions comprising and methods of making and using the same ORTHO-MCNEIL PHARMACEUTICALS, INC. (US) 2008-04-01 US disclosed
US-7351695-B2 Topiramate salts and compositions comprising and methods of making and using the same ORTHO-MCNEIL PHARMACEUTICALS, INC. (US) 2008-04-01 US disclosed
US-20040053853-A1 Topiramate salts and compositions comprising and methods of making and using the same ORTHO-MCNEILL PHARMACEUTICAL, INC. 2004-03-18 US disclosed
US-6699840-B2 COMPRISING TOPIRAMATE SODIUM TRIHYDRATE AND MEANS FOR CONTROLLED- OR DELAYED-RELEASE THEREOF TRANSFORM PHARMACEUTICALS, INC. 2004-03-02 US disclosed
US-20030166581-A1 Topiramate salts and compositions comprising them ORTHO-MCNEILL PHARMACEUTICAL, INC. 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053853-A1 Topiramate salts and compositions comprising and methods of making and using the same SCN3A, CACNA1H, KCNQ3 CA2 207/4885CA4 459/4885CA1 473/4885
US-20030166581-A1 Topiramate salts and compositions comprising them SCN3A, SCN1A, KCNQ3 CA2 234/4885CA4 611/4885CA1 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.